Anouk Jochems

677 total citations
14 papers, 297 citations indexed

About

Anouk Jochems is a scholar working on Oncology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Anouk Jochems has authored 14 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Anouk Jochems's work include Cutaneous Melanoma Detection and Management (7 papers), Computational Drug Discovery Methods (3 papers) and CAR-T cell therapy research (3 papers). Anouk Jochems is often cited by papers focused on Cutaneous Melanoma Detection and Management (7 papers), Computational Drug Discovery Methods (3 papers) and CAR-T cell therapy research (3 papers). Anouk Jochems collaborates with scholars based in Netherlands, United States and Germany. Anouk Jochems's co-authors include J.J.W.A. Boei, Gido Gravesteijn, Daniel Houtsma, Hanno Pijl, Marij J.P. Welters, Stefanie de Groot, Maaike P.G. Vreeswijk, Hein Putter, Judith R. Kroep and J.W.R. Nortier and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and BMJ Open.

In The Last Decade

Anouk Jochems

13 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anouk Jochems Netherlands 5 140 101 69 64 45 14 297
Pei‐Ju Lien Taiwan 9 91 0.7× 81 0.8× 158 2.3× 51 0.8× 61 1.4× 33 367
María Laura Rossi Argentina 6 62 0.4× 58 0.6× 60 0.9× 32 0.5× 38 0.8× 20 343
Heba Zahid Saudi Arabia 8 69 0.5× 155 1.5× 104 1.5× 24 0.4× 85 1.9× 11 319
Ildikó Ungvári Hungary 10 86 0.6× 87 0.9× 87 1.3× 51 0.8× 15 0.3× 11 301
Barbara Kunz United States 6 141 1.0× 26 0.3× 42 0.6× 48 0.8× 27 0.6× 9 277
Tanja Stocks Sweden 6 48 0.3× 105 1.0× 128 1.9× 61 1.0× 131 2.9× 7 291
Nora Mirza Germany 7 106 0.8× 63 0.6× 111 1.6× 64 1.0× 11 0.2× 12 335
Candace Carter Australia 7 73 0.5× 87 0.9× 21 0.3× 123 1.9× 29 0.6× 12 269
Katashi Okuma Japan 10 92 0.7× 41 0.4× 99 1.4× 38 0.6× 29 0.6× 13 393
Erin Brock Australia 7 57 0.4× 37 0.4× 140 2.0× 51 0.8× 110 2.4× 8 336

Countries citing papers authored by Anouk Jochems

Since Specialization
Citations

This map shows the geographic impact of Anouk Jochems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anouk Jochems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anouk Jochems more than expected).

Fields of papers citing papers by Anouk Jochems

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anouk Jochems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anouk Jochems. The network helps show where Anouk Jochems may publish in the future.

Co-authorship network of co-authors of Anouk Jochems

This figure shows the co-authorship network connecting the top 25 collaborators of Anouk Jochems. A scholar is included among the top collaborators of Anouk Jochems based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anouk Jochems. Anouk Jochems is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dings, Mark P.G., Jan Köster, Mariëtte Labots, et al.. (2025). KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer. Med. 6(6). 100601–100601. 1 indexed citations
2.
Bos, Frederiek van den, Marije Slingerland, Gerrit‐Jan Liefers, et al.. (2024). DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients. BMJ Open. 14(8). e089882–e089882.
3.
Glas, Nienke A. de, Gerrit‐Jan Liefers, Marije Slingerland, et al.. (2023). Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population‐based study. International Journal of Cancer. 152(10). 2043–2051. 3 indexed citations
4.
Jochems, Anouk, et al.. (2023). Two patients with fluoropyrimidine overdose successfully managed without uridine triacetate. Journal of Oncology Pharmacy Practice. 29(8). 2037–2040. 2 indexed citations
5.
Zeijl, Michiel C.T. van, John B.A.G. Haanen, Michel W.J.M. Wouters, et al.. (2020). Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study. Journal of Immunotherapy. 43(8). 256–264. 11 indexed citations
6.
Zeijl, Michiel C.T. van, Liesbeth C. de Wreede, Alfons J.M. van den Eertwegh, et al.. (2020). Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry. European Journal of Cancer. 144. 242–251. 13 indexed citations
7.
Horeweg, Nanda, et al.. (2019). Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study. Supportive Care in Cancer. 28(3). 1097–1107. 51 indexed citations
8.
Schouwenburg, Maartje G., Karijn P.M. Suijkerbuijk, Rutger H.T. Koornstra, et al.. (2019). Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?. Cancers. 11(12). 1940–1940. 28 indexed citations
9.
Wouters, Michel W.J.M., Anouk Jochems, Maartje G. Schouwenburg, et al.. (2018). [Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry].. PubMed. 162. 4 indexed citations
10.
Eertwegh, Alfons J.M. van den, Michel W.J.M. Wouters, Anouk Jochems, et al.. (2018). Recente behandelresultaten van uitgezaaid melanoom. Data Archiving and Networked Services (DANS). 162(26). 1–10. 1 indexed citations
11.
Brouwer, Niels J., Marina Marinkovic, Anouk Jochems, et al.. (2017). Conjunctival Metastasis of a Cutaneous Melanoma. Ocular Oncology and Pathology. 4(2). 107–111. 4 indexed citations
12.
Groot, Stefanie de, Maaike P.G. Vreeswijk, Marij J.P. Welters, et al.. (2015). The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 15(1). 652–652. 173 indexed citations
13.
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei‐Ju Lien Breakdown of academic impact, for papers by María Laura Rossi Breakdown of academic impact, for papers by Heba Zahid Breakdown of academic impact, for papers by Ildikó Ungvári Breakdown of academic impact, for papers by Barbara Kunz Breakdown of academic impact, for papers by Tanja Stocks Breakdown of academic impact, for papers by Nora Mirza Breakdown of academic impact, for papers by Candace Carter Breakdown of academic impact, for papers by Katashi Okuma Breakdown of academic impact, for papers by Erin Brock
Rankless by CCL
2026